CAR T-cell therapy for lymphoma and multiple myeloma

被引：0
|
作者：
Kochenderfer, James N. [1 ]
机构：
[1] NCI, NIH, Bethesda, MD 20892 USA
来源：
CANCER IMMUNOLOGY RESEARCH | 2019年 / 7卷 / 02期
关键词：
D O I：
10.1158/2326-6074.CRICIMTEATIAACR18-IA12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA12
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Determinants of Response and Mechanisms of Resistance of CAR T-cell Therapy in Multiple Myeloma
    van de Donk, Niels W. C. J.
    Themeli, Maria
    Usmani, Saad Z.
    BLOOD CANCER DISCOVERY, 2021, 2 (04): : 302 - 318
  • [22] CAR T-Cell Therapy for Patients with Multiple Myeloma: Current Evidence and Challenges
    Rendo, Matthew J.
    Joseph, Jacinth J.
    Phan, Liem Minh
    DeStefano, Christin B.
    BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2022, 12 : 119 - 136
  • [23] T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myeloma
    Garfall, Alfred L.
    Dancy, Ehren K.
    Cohen, Adam D.
    Hwang, Wei-Ting
    Fraietta, Joseph A.
    Davis, Megan M.
    Levine, Bruce L.
    Siegel, Don L.
    Stadtmauer, Edward A.
    Vogl, Dan T.
    Waxman, Adam
    Rapoport, Aaron P.
    Milone, Michael C.
    June, Carl H.
    Melenhorst, J. Joseph
    BLOOD ADVANCES, 2019, 3 (19) : 2812 - 2815
  • [24] CAR T-cell therapy for follicular lymphoma and mantle cell lymphoma
    Mohty, Razan
    Kharfan-Dabaja, Mohamed A.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [25] CAR T-cell therapy for follicular lymphoma and mantle cell lymphoma
    Mohty, Razan
    Kharfan-Dabaja, Mohamed A.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [26] Mechanisms of Resistance and Treatment of Relapse after CAR T-cell Therapy for Large B-cell Lymphoma and Multiple Myeloma
    Rejeski, Kai
    Jain, Michael D.
    Smith, Eric L.
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (07): : 418 - 428
  • [27] CAR T-cell therapy: is it prime time in myeloma?
    Sidana, Surbhi
    Shah, Nina
    BLOOD ADVANCES, 2019, 3 (21) : 3473 - 3480
  • [28] CAR T-cell therapy: is it prime time in myeloma?
    Sidana, Surbhi
    Shah, Nina
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2019, : 260 - 265
  • [29] Updates on CAR T cell therapy in multiple myeloma
    Nasiri, Fatemeh
    Asaadi, Yasaman
    Mirzadeh, Farzaneh
    Abdolahi, Shahrokh
    Molaei, Sedigheh
    Gavgani, Somayeh Piri
    Rahbarizadeh, Fatemeh
    BIOMARKER RESEARCH, 2024, 12 (01)
  • [30] CAR T-Cell Therapy Against B-Cell Maturation Antigen in Multiple Myeloma
    Cohen, Adam D.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (12) : 804 - 806
12345